Pelizaeus-Merzbacher disease (PMD) is a demyelinating disorder of the CNS belonging to the group of hypomyelination leukodystrophies. This activity describes the evaluation and management of Pelizaeus-Merzbacher disease and explains the role of the interprofessional team in evaluating and improving care for patients with this condition.

**Objectives:**
- Identify the etiology of Pelizaeus-Merzbacher disease.
- Outline the appropriate evaluation of Pelizaeus-Merzbacher disease.
- Review the management options available for Pelizaeus-Merzbacher disease.
- Discuss interprofessional team strategies for improving care coordination and communication to advance Pelizaeus-Merzbacher disease and improve outcomes.